Inactive Instrument

Other languages Lombard Medical Inc Nasdaq

Equities

KYG555981094

Other languages

Unlock all the news: Be the first to know and act before the market!

Lombard Medical, Inc.(NasdaqCM:EVAR) dropped from NASDAQ Composite Index	08/11/17
Lombard Medical, Inc. Announces Unaudited Earnings Results for the Third Quarter Ended September 30, 2017; Provides Earnings Guidance for the Fourth Quarter of 2017 and Fiscal Year 2018	31/10/17
Lombard Medical, Inc. Announces Full Commercial Launch of Japan of its New Low-Profile IntelliFlex LP Delivery System for the Aorfix AAA System	26/09/17
Lombard Medical, Inc. Appoints Jonathan Hornsby as Vice President, Sales & Marketing	20/09/17
Lombard Medical, Inc. Announces Resignation of William J. Kullback as Chief Financial Officer, Effective May 5, 2017	28/04/17
Lombard Medical, Inc. Appoints Kurt Lemvigh as CEO	20/04/17
Lombard Medical, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2016; Reports Impairment-Goodwill and Long-Lived Intangibles for the Fourth Quarter of 2016	18/04/17
Simon Hubbert Steps Down from Lombard Medical, Inc. as CEO	18/04/17
Lombard Medical, Inc. and MicroPort Scientific Corporation Finalize Strategic Partnership Agreements	03/04/17
Lombard Medical, Inc. Announces Board Changes	19/12/16
Lombard Medical, Inc. and MicroPort Scientific Corporation Announce Strategic Partnership	19/12/16
Lombard Medical, Inc. announced that it has received $15 million in funding from MicroPort NeuroTech Co., Ltd., MicroPort NeuroTech CHINA Corp. Limited	17/12/16
Lombard Medical, Inc. Announces Positive Long-Term Data for Aorfix™	05/12/16
Lombard Medical, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2016	27/10/16
Lombard Medical, Inc. Wins GBP 202.7 Million Multiple Awardees Contract	26/10/16
Invesco Intends to Engage in Discussions with Lombard Medical	15/09/16
Lombard Medical, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2016	22/08/16
Lombard Medical Seeks Strategic Alternatives	22/08/16
Lombard Medical, Inc. Announces CE Mark Approval for IntelliFlex™ LP Delivery System for the Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft	20/06/16
Lombard Medical, Inc. Plans to Conduct 1,000 Patient Global Registry to Evaluate New Altura Endograft System	15/06/16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Lombard Medical Inc Nasdaq

Equities

KYG555981094

Other languages

Filters